4.5 Review

Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers

Publisher

SPRINGER
DOI: 10.1007/s10096-023-04548-2

Keywords

ESBL; SDD; FMT; Bacteriophages; Probiotics; Microcins

Ask authors/readers for more resources

Infections caused by ESBL- and/or carbapenemase-producing Enterobacterales (Ent) have had a significant clinical impact globally. These multidrug-resistant (MDR) pathogens, particularly Escherichia coli and Klebsiella pneumoniae, can cause infections originating from asymptomatic intestinal colonization, leading to potential transmission. Rapid identification of gut carriers is important for preventing serious infections and transmission. This review summarizes various aspects of intestinal colonization by MDR-Ent, including screening techniques, prevalence and risk factors, clinical impact, colonization duration, and strategies for decolonization.
The clinical impact of infections due to extended-spectrum beta-lactamase (ESBL)- and/or carbapenemase-producing Enterobacterales (Ent) has reached dramatic levels worldwide. Infections due to these multidrug-resistant (MDR) pathogens-especially Escherichia coli and Klebsiella pneumoniae-may originate from a prior asymptomatic intestinal colonization that could also favor transmission to other subjects. It is therefore desirable that gut carriers are rapidly identified to try preventing both the occurrence of serious endogenous infections and potential transmission. Together with the infection prevention and control countermeasures, any strategy capable of effectively eradicating the MDR-Ent from the intestinal tract would be desirable. In this narrative review, we present a summary of the different aspects linked to the intestinal colonization due to MDR-Ent. In particular, culture- and molecular-based screening techniques to identify carriers, data on prevalence and risk factors in different populations, clinical impact, length of colonization, and contribution to transmission in various settings will be overviewed. We will also discuss the standard strategies (selective digestive decontamination, fecal microbiota transplant) and those still in development (bacteriophages, probiotics, microcins, and CRISPR-Cas-based) that might be used to decolonize MDR-Ent carriers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available